4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in 4D Molecular Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −5 vs. Q1 2025
- Shares held
- 40.4M
- −2.69M (−6.2%) vs. Q1 2025
- Total value
- $149.9M
- +$10.0M (+7.2%) vs. Q1 2025
- New holders
- 17
- 43 more added
- Sold out
- 22
- 40 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $771.2M |
| Q1 2026 | 153 | $471.4M |
| Q4 2025 | 153 | $400.5M |
| Q3 2025 | 134 | $343.2M |
| Q2 2025 | 121 | $149.9M |
| Q1 2025 | 126 | $139.8M |
| Q4 2024 | 146 | $260.6M |
| Q3 2024 | 140 | $629.2M |
| Q2 2024 | 143 | $1.20B |
| Q1 2024 | 147 | $1.79B |
| Q4 2023 | 111 | $859.8M |
| Q3 2023 | 110 | $533.6M |
| Q2 2023 | 100 | $745.3M |
| Q1 2023 | 94 | $522.3M |
| Q4 2022 | 96 | $621.9M |
| Q3 2022 | 88 | $210.4M |
| Q2 2022 | 90 | $181.7M |
| Q1 2022 | 80 | $395.3M |
| Q4 2021 | 77 | $541.8M |
| Q3 2021 | 63 | $515.1M |
| Q2 2021 | 56 | $400.0M |
| Q1 2021 | 64 | $664.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 330,591 | $1.23M | 0.00% | −70,015−17.5% | Reduced |
| Raymond James Financial Inc | 455,470 | $1.69M | 0.00% | +161,091+54.7% | Added |
| ArrowMark Colorado Holdings LLC | 514,614 | $1.91M | 0.03% | −12,656−2.4% | Reduced |
| Two Sigma Investments, LP | 531,163 | $1.97M | 0.00% | +69,706+15.1% | Added |
| Assenagon Asset Management S.A. | 648,825 | $2.41M | 0.00% | −2,131−0.3% | Reduced |
| Two Sigma Advisers, LP | 743,400 | $2.76M | 0.01% | +253,000+51.6% | Added |
| JPMorgan Chase & Co | 888,016 | $3.29M | 0.00% | +1,311+0.1% | Added |
| Bank of America Corp | 897,070 | $3.33M | 0.00% | +198,762+28.5% | Added |
| Geode Capital Management, LLC | 918,533 | $3.41M | 0.00% | −44,736−4.6% | Reduced |
| Morgan Stanley | 924,676 | $3.43M | 0.00% | −852,067−48.0% | Reduced |
| State Street Corp | 961,962 | $3.57M | 0.00% | −65,988−6.4% | Reduced |
| Millennium Management LLC | 1,483,724 | $5.50M | 0.00% | −150,263−9.2% | Reduced |
| Federated Hermes, Inc. | 1,667,338 | $6.19M | 0.01% | +417,157+33.4% | Added |
| Janus Henderson Group PLC | 1,754,410 | $6.51M | 0.00% | −137,525−7.3% | Reduced |
| Novo Holdings A/S | 2,000,000 | $7.42M | 0.52% | +50,000+2.6% | Added |
| Vanguard Group Inc | 2,736,671 | $10.2M | 0.00% | −20,819−0.8% | Reduced |
| BlackRock, Inc. | 4,010,755 | $14.9M | 0.00% | −536,397−11.8% | Reduced |
| Goldman Sachs Group Inc | 4,159,264 | $15.4M | 0.00% | −9,130−0.2% | Reduced |
| Ra Capital Management, L.P. | 4,563,211 | $16.9M | 0.29% | 00.0% | Unchanged |
| BVF Inc | 4,629,289 | $17.2M | 0.61% | +68,000+1.5% | Added |
| DekaBank Deutsche Girozentrale | 30,000 | – | – | 00.0% | Unchanged |
| VR Adviser, LLC | 0 | $0 | 0.00% | −677,600−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −412,000−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −247,471−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −84,175−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −84,172−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −43,080−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −36,909−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −32,811−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −30,605−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −23,864−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −22,059−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −21,707−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −15,295−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −12,981−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −12,627−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,836−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −6,502−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −3,677−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −628−100.0% | Sold out |
| Aventura Private Wealth, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |